Additionally, survivin serves as both a diagnosticand prognostic marker, as its high expression correlates with poorerclinical outcomes, higher recurrence rates, and reduced patient survival.Thus, modulating survivin represents a promising therapeutic strategyto improve the effectiveness of breast cancer treatment., The gene discussed is BIRC5; the disease is breast cancer.